MC
GEHC icon

Moors & Cabot’s GE HealthCare GEHC Stock Holding History

Moors & Cabot’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$936K Sell
13,152
-1,359
-9% -$107K 0.04% 387
2025
Q4 		$1.19M Sell
14,511
-2,562
-15% -$200K 0.05% 314
2025
Q3 		$1.28M Buy
17,073
+7,531
+79% +$562K 0.06% 302
2025
Q2 		$707K Buy
9,542
+374
+4% +$26K 0.03% 419
2025
Q1 		$740K Sell
9,168
-607
-6% -$52.2K 0.04% 385
2024
Q4 		$764K Sell
9,775
-125
-1% -$10.6K 0.04% 391
2024
Q3 		$929K Sell
9,900
-64
-0.6% -$5.37K 0.05% 350
2024
Q2 		$776K Sell
9,964
-4,434
-31% -$362K 0.04% 363
2024
Q1 		$1.31M Sell
14,398
-6,115
-30% -$509K 0.07% 249
2023
Q4 		$1.59M Buy
20,513
+133
+0.7% +$9.31K 0.1% 195
2023
Q3 		$1.39M Buy
20,380
+2,713
+15% +$197K 0.09% 207
2023
Q2 		$1.44M Buy
17,667
+2,282
+15% +$182K 0.1% 206
2023
Q1 		$1.26M Buy
+15,385
New +$1.1M 0.09% 231

Other funds holding GEHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Moors & Cabot's GEHC Position: Q1 2026 in Review

Moors & Cabot reduced its GE HealthCare (GEHC) stake by 9.4% in Q1 2026, selling an estimated $107K and leaving 13,152 shares worth $936K. The position accounts for 0.04% of the portfolio, ranked #387.

Moors & Cabot first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.59M in Q4 2023. 1,269 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Moors & Cabot held 13,152 shares of GE HealthCare worth $936K as of Q1 2026.
  • Moors & Cabot sold 1,359 GE HealthCare shares in Q1 2026, an estimated $107K.
  • GE HealthCare made up 0.04% of Moors & Cabot's portfolio in Q1 2026, its #387 holding.
  • Moors & Cabot first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Moors & Cabot's GE HealthCare position peaked at $1.59M in Q4 2023.
  • 1,269 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.